This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovorafenib in R/R Pediatric Low Grade Glioma"

107 views
July 11, 2024
0 Comments
Login to view comments. Click here to Login